How the common cold may help protect against Covid-19
New research suggests ‘memory bank’ of T-cells triggered by colds boosts Covid defences
People who have fought off common colds may have a lower risk of catching Covid-19, according to a newly published study.
The research findings, outlined in a paper in Nature Communications journal, help to “explain why some people never get infected” with Covid, and why older people are “more susceptible” than children, who tend to pick up colds more frequently, said The Telegraph.
In the small-scale study, scientists from Imperial College London (ICL) tested blood taken from 52 people in September 2020 – before Covid vaccines were rolled out – who were living with others who had just tested positive for the coronavirus. A total of 26 went on to get Covid during the 28-day study period.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In a bid to determine why the other half of the group escaped infection, the researchers looked at “a crucial part of the body’s immune system – T-cells”, said the BBC.
Some of these T-cells “kill any cells infected by a specific threat”, such as a cold virus, the broadcaster explained. And following a cold infection, some “remain in the body as a memory bank, ready to mount a defence against future attacks” by the virus.
The researchers found that the 26 test subjects who did not contract Covid had “significantly higher levels” of “pre-existing T-cells induced by previous common cold coronavirus infections that also cross-recognise proteins” of Sars-CoV-2, the virus that causes Covid-19, according to the ICL website.
‘Blueprint’ for future vaccines
The findings suggest that these protective T-cells may be present in “a good proportion of the population”, study co-author Professor Ajit Lalvani told The Telegraph.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
“It explains the good outcomes or resistance to infection for some people,” added Lalvani, director of the NIHR Respiratory Infections Health Protection Research Unit at Imperial.
The researchers believe that the “important discovery” may provide a “blueprint” for the production of a new universal vaccine that “could prevent infection from current and future Sars-CoV-2 variants, including Omicron”, said the ICL website.
Dr Rhia Kundu, first author of the study, stressed that “no one should rely on this alone”, adding: “The best way to protect yourself against Covid-19 is to be fully vaccinated, including getting your booster dose.”
The team and other scientists pointed out that not all colds are coronaviruses. Dr Simon Clarke, of the University of Reading, who was not involved in the study, said: “It could be a grave mistake to think that anyone who has recently had a cold is protected against Covid-19, as coronaviruses only account for 10%-15% of colds.”
Experts said that “other variables – such as ventilation and how infectious their household contact was – would have an impact” on whether people caught Covid, too, the BBC reported.
All the same, said study co-author Lalvani, “learning from what the body does right could help inform the design of new vaccines”.
Current vaccines target spike proteins that sit on the outside of the Covid virus, but those spike proteins can change with new variants.
“In contrast, the internal proteins targeted by the protective T-cells we identified mutate much less,” Lalvani explained. So new vaccines that include these internal proteins would “induce broadly protective T-cell responses that should protect against current and future Sars-CoV-2 variants.”
-
Why Man United finally lost patience with ten Hag
Talking Point After another loss United sacked ten Hag in hopes of success in the Champion's League
By The Week UK Published
-
Who are the markets backing in the US election?
Talking Point Speculators are piling in on the Trump trade. A Harris victory would come as a surprise
By The Week UK Published
-
Crossword: November 3, 2024
The Week's daily crossword
By The Week Staff Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published